|
Lozano M., Rivera J., Vicente V. Platelet concentrates from whole-blood donations (buffy-coat) or apheresis: Which one to use?. Medicina Clinica. 5 May 2012. 138:528-533. 10.1016/j.medcli.2011.05.008
AÑO: 2012; IF: 1.399
|
|
Montoro-García S, Shantsila E, Orenes-Piñero E, Lozano ML, Lip GY. An innovative flow cytometric approach for small-size platelet microparticles: influence of calcium. Thromb Haemost. 2012 Aug;108(2):373-83. doi: 10.1160/TH12-02-0120. Epub 2012 Jun 28. PubMed PMID: 22740162.
AÑO: 2012; IF: 6.094
|
|
Leandro-García LJ, Leskelä S, Inglada-Pérez L, Landa I, de Cubas AA, Maliszewska A, Comino-Méndez I, Letón R, Gómez-Graña Á, Torres R, Ramírez JC, Álvarez S, Rivera J, Martínez C, Lozano ML, Cascón A, Robledo M, Rodríguez-Antona C. Hematologic ?-tubulin VI isoform exhibits genetic variability that influences paclitaxel toxicity. Cancer Res. 2012 Sep 15;72(18):4744-52. doi: 10.1158/0008-5472.CAN-11-2861. Epub 2012 Jul 17. PubMed PMID: 22805305.
AÑO: 2012; IF: 8.65
|
|
Navarro-Núñez L, Teruel R, Antón AI, Nurden P, Martínez-Martínez I, Lozano ML, Rivera J, Corral J, Mezzano D, Vicente V, Martinez C. Rare homozygous status of P43 ?1-tubulin polymorphism causes alterations in platelet ultrastructure. Thromb Haemost. 2011 May;105(5):855-63. doi: 10.1160/TH10-08-0536. Epub 2011 Mar 8. PubMed PMID: 21384078.
AÑO: 2011; IF: 5.044
|
|
Lozano M. Controversies: Apheresis or pooled platelets, pros and cons. Blood Transfusion. 2011. 9.
AÑO: 2011; IF: 2.099
|